Epithelial chips of human foreskin or cervix infected in vitro with one strain of human papillomavirus type 11 (HPV-11) and subsequently transplanted to the renal capsule of athymic mice will yield, after 3 months of in vivo incubation, epithelial cysts that are morphologically transformed and appear identical in every way to human condylomata. These cysts synthesize virus RNA, DNA, proteins, and infectious virions. The cysts can be utilized as a source of virus for continued passage of infection. The original HPV-11 infecting material was a cell-free saline extract of pooled human vulvar condylomata. DNAs of other HPV types were not detected in this material by either dot blot or Southern blot analyses. The copy number of HPV-11 virus genomes per cell genome in experimental condylomata ranged from about 200 to 1,000, a range expected for episomal papillomavirus DNA. Analyses of cloned HPV-11 DNA (pBT-1) from experimental lesions demonstrated that the size and restriction endonuclease map of the HPV-11-Hershey isolate closely matched that of the prototype. A few nucleotide changes that were detected during analyses of pBT-1 DNA resulted either in no amino acid change or a conservative change of amino acid. Physical characterization of the cloned experimental HPV-11 DNA as well as HPV typing in clinical lesions and experimental cysts are presented.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.